萌赞网

暂无描述...

祖百科 - 你的生活百科全书

祖百科

后端仔的奇妙冒险 – Wonderful adventures of a developer

Wonderfuladventuresofadeveloper

浸塑设备_大旋风喷房_喷塑设备_喷漆设备-扬州海诚科技发展有限公司

扬州海诚科技发展有限公司是集研发,设计浸塑设备为一体的实业公司.主要产品有浸塑,浸塑设备,喷涂设备,钢管浸塑设备,护栏网浸塑设备,电泳涂装等.为客户创造最大的成功是我们的宗旨,欢迎新老客户咨询合作.

上海乐展电器有限公司-上海振动时效设备厂家-振动消除应力装置-超声波消除应力装置-上海乐展电器有限公司

上海乐展电器有限公司专注于振动时效设备,振动消除应力装置,超声波消除应力装置等设备制造与销售.我司拥有国内外先进的生产技术和设备,能够保证设备质量,价格优惠,使用寿命长,维保简单,厂家货源,售后更放心.24小时业务咨询热线18918007705.

象山基督教爵溪教堂

浙江省宁波市象山基督教爵溪教堂位于浙江省宁波市象山县爵溪街道，是合法的宗教场所，获得象山县首批互联网宗教服务许可证，在公信部已ICP报备收录.

Almos 天气

查看Almos天气上的最新天气预报。

神农架道地药材产业发展有限公司

神农架道地药材产业发展有限公司

WestVac Biopharma

WestVacBiopharmaisfoundedbyAcademicianWeiYuquanfromWestChinaHospitalofSichuanUniversity,togetherwith10scientistsfromStateKeyLaboratoryofBiotherapy(SKLB).ItsheadquarterislocatedintheInternationalBio-Town,Chengdu.TheCEOofWestVacBiopharmaisProf.WeiYuquan,whoistheAcademicianofChineseAcademyofSciencesaswellastheDirectorofStateKeyLaboratoryofBiotherapy.WestVaciscommittedtoexploringthelatestbiotherapytechnologiesformajordiseases,includinginfectiousdiseases,malignanttumors,cardiovasculardiseases,andsoon.IthasattachedgreatimportanceintheResearchandDevelopment(R&D)ofCOVID-19vaccineespeciallyandbuildingaCOVID-19vaccineproductionplatform.StateKeyLaboratoryofBiotherapy(SKLB)wasestablishedbytheMinistryofSciencesandTechnologyofChinain2005andbecameoneoftheNationalR&DPlatformsforNovelDrugsfoundedbytheMinistriesofSciencesandTechnologyaswellasthatofHealthofChinain2008.ItisalsosupportedbyNationalCollaborativeInnovationProgramandhasbecometheNationalCollaborativeInnovationCenterforBiotherapysince2013.WestChinaHospitalofSichuanUniversity，foundedin1892,istheNationalCenterforDiagnosisandTreatmentofSevereandCriticalDiseasesinWesternChina.Itisalsotheworld’slargestcomprehensivehospitalcomplexlocatedinonecampusarea.RelyingonthemedicalresourcesofStateKeyLaboratoryofBiotherapyandWestChinaMedicalCenter,WestVachasadoptedrecombinantproteinmethodologytodeveloptheCOVID-19vaccine.Becauseofthesafetyoftheproteinvaccine,itisalsotheonlyCOVID-19vaccineapprovedfortheuseinchildrenover3yearsoldinChina.ThevaccinewasapprovedbytheNationalMedicalProductsAdministrationforclinicaltrialsonAugust21,2020.PhaseI/IIclinicaltrialshavebeencompleted,andphaseIIIclinicaltrialsarebeingcarriedoutinNepal,Kenya,Japanandothercountries.Thevaccinetargetsthespikeproteinbindingdomain(S-RBD)ofSARS-CoV-2,producingneutralizingantibodiestoblockCOVID-19infectionofhumancells.TheresultwaspublishedonNature,theworld’sfamousscientificjournalonJuly29th,2020.IthasalsobeenthefirstpaperofCOVIDvaccinepublishedbyNaturesincethepandemicoutbreak.TheS-RBDgeneoftheCOVID-19virusisintroducedintotheinsectcells,whichwereusedasafactorytoproducehigh-qualityrecombinantvaccineproteinandthendoesrefinedpurification.Suchtechnologyiseasytobemass-producedandbroughttothemarket.WestVacBiopharmaiscommittedtobecomingtheworld`sleadingvaccineandimmunotherapyplatform.